U.S. Stock Market Movement: Charles River soars on September 24 following reaffirmed guidance, 2030 target, and CRO

Charles River September 24 Major Gain Analysis

Keywords: Guidance reiteration, 2030 target, CRO

1. On September 24, the company reiterated its FY2026 guidance at its Investor Day, expecting revenue and non-GAAP earnings per share to be at the upper end of the previously announced range.

2. On September 24, the company announced long-term financial targets through 2030, expecting an organic revenue compound annual growth rate of 5%–7%, and plans to save over $300 million cumulatively from 2027 to 2030 through the “Create the Future” project.

3. On September 24, the company released its “Pathway to Purpose” strategy, focusing on advancing business modernization, expanding its scientific product portfolio, utilizing digital tools, and enhancing customer experience to strengthen its positioning as a scientific partner in the biopharmaceutical industry.

(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)